Skye Bioscience, Inc. (SKYE)
NASDAQ·Healthcare·Biotechnology
$0.93
-12.45%
Mkt Cap $37.23M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$2.00
Range $2.00 – $2.00
Implied Upside
+115.5%
Consensus $2.00 vs current $0.93
NASDAQ·Healthcare·Biotechnology
$0.93
-12.45%
Mkt Cap $37.23M
No recent rating data.
Price Target (8 analysts)
$2.00
Range $2.00 – $2.00
+115.5%
Consensus $2.00 vs current $0.93